These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
660 related articles for article (PubMed ID: 18695711)
1. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Kulasingam V; Diamandis EP Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711 [TBL] [Abstract][Full Text] [Related]
2. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics. Bharti A; Ma PC; Salgia R Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130 [TBL] [Abstract][Full Text] [Related]
4. Dependence network modeling for biomarker identification. Qiu P; Wang ZJ; Liu KJ; Hu ZZ; Wu CH Bioinformatics; 2007 Jan; 23(2):198-206. PubMed ID: 17077095 [TBL] [Abstract][Full Text] [Related]
5. Proteomics for the identification of new prostate cancer biomarkers. Ornstein DK; Tyson DR Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055 [TBL] [Abstract][Full Text] [Related]
6. Cancer proteomics: Serum diagnostics for tumor marker discovery. Rai AJ; Chan DW Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974 [TBL] [Abstract][Full Text] [Related]
8. Proteomic approaches in lung cancer biomarker development. Cho JY; Sung HJ Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatics strategies for translating genome-wide expression analyses into clinically useful cancer markers. Rhodes DR; Chinnaiyan AM Ann N Y Acad Sci; 2004 May; 1020():32-40. PubMed ID: 15208181 [TBL] [Abstract][Full Text] [Related]
14. Proteomics of breast carcinoma. Somiari RI; Somiari S; Russell S; Shriver CD J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811 [TBL] [Abstract][Full Text] [Related]
15. The molecular make-up of a tumour: proteomics in cancer research. Kolch W; Mischak H; Pitt AR Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087 [TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery. Matta A; Ralhan R; DeSouza LV; Siu KW Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361 [TBL] [Abstract][Full Text] [Related]
17. The footprints of cancer development: Cancer biomarkers. Ullah MF; Aatif M Cancer Treat Rev; 2009 May; 35(3):193-200. PubMed ID: 19062197 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers for lung cancer: clinical uses. Greenberg AK; Lee MS Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168 [TBL] [Abstract][Full Text] [Related]
19. Proteomics and the haematologist. Rees-Unwin KS; Morgan GJ; Davies FE Clin Lab Haematol; 2004 Apr; 26(2):77-86. PubMed ID: 15053800 [TBL] [Abstract][Full Text] [Related]
20. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer. Peng XQ; Wang F; Geng X; Zhang WM Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]